25-Hydroxyvitamin D in the range of 20 to 100 ng/mL and incidence of kidney stones

American Journal of Public Health, 104(9), 1783-1787

DOI 10.2105/AJPH.2013.301368 PMID 24134366

Abstract

Objectives

Increasing 25-hydroxyvitamin D serum levels can prevent a wide range of diseases. There is a concern about increasing kidney stone risk with vitamin D supplementation. We used GrassrootsHealth data to examine the relationship between vitamin D status and kidney stone incidence.

Methods

The study included 2012 participants followed prospectively for a median of 19 months. Thirteen individuals self-reported kidney stones during the study period. Multivariate logistic regression was applied to assess the association between vitamin D status and kidney stones.

Results

We found no statistically significant association between serum 25-hydroxyvitamin D and kidney stones (P = .42). Body mass index was significantly associated with kidney stone risk (odds ratio = 3.5; 95% confidence interval = 1.1, 11.3).

Conclusions

We concluded that a serum 25-hydroxyvitamin D level of 20 to 100 nanograms per milliliter has no significant association with kidney stone incidence.

Topics

25-hydroxyvitamin D kidney stone incidence, vitamin D supplementation kidney stone risk, serum vitamin D level nephrolithiasis, vitamin D safety kidney stone concern, GrassrootsHealth vitamin D kidney data, vitamin D 20 to 100 ng/mL safety, vitamin D disease prevention kidney risk, vitamin D supplementation adverse effects, calcium metabolism kidney stone formation
PMID 24134366 24134366 DOI 10.2105/AJPH.2013.301368 10.2105/AJPH.2013.301368

Cite this article

Nguyen, S., Baggerly, L., French, C., Heaney, R. P., Gorham, E. D., & Garland, C. F. (2014). 25-Hydroxyvitamin D in the range of 20 to 100 ng/mL and incidence of kidney stones. *American journal of public health*, *104*(9), 1783-1787. https://doi.org/10.2105/AJPH.2013.301368

Related articles